Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Piperacillin-Tazobactam Prolonged vs Standard Infusion in Obesity
NCT06690905Phase 4Completed
- Sponsor
- Centre de recherche Charles-Le Moyne
- Start
- Feb 2025
- Primary completion
- Sep 2025
- Modality
- Irreversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of piperacillin + tazobactam in Infection, sponsored by Centre de recherche Charles-Le Moyne. Started Feb 2025; status: completed.
02
Drugs
piperacillin + tazobactam
03
Conditions
Infection
Beyond the preview
Go deeper on NCT06690905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06690905.